Urinary Catheters Market: By Indication (Spinal Cord Injuries, Benign Prostatic Hyperplasia, Others) By Gender (Female Urinary Catheters and Male Urinary Catheters) By Type (Uncoated Catheters and Coated Catheters) By Product (External Catheters, Intermittent Catheters, and Indwelling Catheters) By End-User (Long-Term Care Facilities, Hospitals and Other)Regional Analysis & Forecast - 2026
- OI-143 |
- Published date: Jul, 2019 |
- Medical Devices |
- 120 Pages
Introduction
Urinary catheters are often associated with high rates of CAUTI and are responsible for more than 90% of infections in patients. urinary catheters have been used to drain the bladder when it fails to empty. For people with impaired bladder function and for whom the method is feasible, clean intermittent self-catheterization is the optimal procedure.
Market Overview
The Global Urinary Catheters market was valued at $ 3.78 bn in 2018 and is forecasted to grow at a CAGR of 5.7% between 2018 and 2026, resulting in 2026 global sales of $ 5.89 bn. The market is driven by owing rapidly growing geriatric population and rising rates of obesity. However, substitute treatment options for urinary incontinence are hindering the market growth. Moreover, emerging Asian countries to offer growth opportunities are providing ample growth for the market.
Urinary catheters depending on Indications, benign prostate hyperplasia segment is expected to account for the largest share of them due to the common condition in the aging population especially men. According to the Urology Care Foundation, around half of the men in the age of 51 and 60 years have BPH and up to 90% of the men in the age of 80 years have BPH. Acute urinary retention is a serious complication associated with BPH and requires catheterization of the bladder.
Key Developments
Segmentation
The Global Urinary Catheters Market is segmented on the basis of Indication, Gender, Type, Product, End User, and Regions.
Based on the Indication: Spinal Cord Injuries, Benign Prostatic Hyperplasia, General Surgery, Urinary Incontinence, Prostate Gland Surgery, and Urinary Retention.
Based on the Gender: Female Urinary Catheters and Male Urinary Catheters.
Based on the Type: Uncoated Catheters and Coated Catheters.
Based on the Product: External Catheters, Intermittent Catheters, and Indwelling Catheters.
Based on the End User: Long-Term Care Facilities, Hospitals, and Other End Users.
Based on the Region: North America, Asia-Pacific, Europe, and LAMEA. Among that North America held the largest share of the market during 2017, due to suffers from the burden of rising urology diseases and growing geriatric population. According to the American Academy of Family Physicians, urinary incontinence affects approximately 20 million American women and 6 million American men at some point in their lives.
The key players of the Global Urinary Catheters Market include Cook Medical, Hollister Inc., Covidien Plc, Teleflex Inc., Bactiguard, Coloplast A/S, B. Braun Melsungen AG, Medical Technologies of Georgia, Becton, Dickinson, Cure Medical, Llc, Convatec Group Plc, Urocare Products, Inc, Medtronic Plc, Pacific Hospital Supply Co. Ltd, Wellspect Healthcare, J and M Urinary Catheters LLC, Medline Industries, Inc, GE Healthcare, Eckert & Ziegler BEBIG and Dornier MedTech.
Report Description: The report covers an in-depth analysis of the Global Urinary Catheters Market. The report assesses the market products pipeline by stage of development (early development, pre-clinical, clinical and in approval), by Type (Uncoated Catheters and Coated Catheters.). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.
The report includes in-depth company profiles of key players in the Global Urinary Catheters Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments.
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Scope:
- Provides detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Global Urinary Catheters Market
- Provides a comparative analysis of key marketed products and pipeline market products
- Provides key information on players involved in the Global Urinary Catheters Market
- Provides a complete overview of market segments and the regional outlook of Global Urinary Catheters Market
- Provides in-depth coverage of key news related to Global Urinary Catheters Market, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates
-
Data Collation (Primary & Secondary)
-
In-house Estimation (Based on proprietary databases and Models)
-
Market Triangulation
-
Forecasting
-
Market-related information is assembled from both primary and secondary sources.
-
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
-
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
-
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.
